MedySapiens, Inc.

Startup
  • Location

    Hall 8.1 - 4YFN Stand 8.1D11.2

Information

MedySapiens converges AI and bioinformatics to solve rare diseases. Recognized as a '2025 Forbes Asia 100 to Watch,' our SaaS solution, MedyCVi, is clinically validated by SNUH and operational in the USA, Taiwan, and the Philippines. We are building a "Digital Healthcare AI Platform" to bridge clinical insights with real-time life-logs. We are here at MWC to ‘plug in’ our technology with global telcos and ecosystem partners. With Series B underway, we invite strategic investors to accelerate our expansion into Europe and the Middle East. Saving lives, one data point at a time.

Key Information

  • Growth Stage
    Series A
  • Country
    Korea, Republic Of
  • Founding Year
    2016